Status:

COMPLETED

Feasibility, Acceptability and Effectiveness of the SOmNI Mobile Phone App for Sleep Promotion in Adolescents

Lead Sponsor:

University of Toronto

Collaborating Sponsors:

Canadian Institutes of Health Research (CIHR)

Conditions:

Sleep Deprivation

Eligibility:

All Genders

13-17 years

Phase:

NA

Brief Summary

This study evaluates the acceptability, feasibility, and efficacy of an intervention using wearable sensors and a mHealth application, SOmNI, to promote sleep for adolescents. The investigators hypoth...

Detailed Description

Over 60% of adolescents sleep less than the 9 hours of sleep recommended for 13-18 year olds. Quality of life is reduced due to the daytime consequences of chronic sleep deprivation such as sleepiness...

Eligibility Criteria

Inclusion

  • enrolled in high school (grades 9 to 12)
  • ages 13-17 years
  • report sleeping \<8 hours per weeknight (Sun-Thurs)
  • endorse daytime sleepiness that interferes with their daily function to a moderate or severe degree (e.g. To what extent do you consider your sleepiness to interfere with your daily functioning (e.g. daytime fatigue, mood, ability to function at school, concentration, memory)
  • report sleeping \>9 hours on weekend nights (Fri-Sat)
  • have either their own iPhone (version 4S or higher) or are willing to use a study-provided iPhone

Exclusion

  • developmental delay (e.g. more than one grade level beyond what is appropriate for age)
  • physician-diagnosed, significant physical health problem (e.g. cystic fibrosis, diabetes, lupus, kidney disease, hypertension, inflammatory bowel disease, etc)
  • physician-diagnosed mental health problem (e.g. anxiety, depression, ADHD),
  • physician-diagnosed sleep disorder (e.g. narcolepsy, obstructive sleep apnea, insomnia, restless leg syndrome)
  • suspected sleep disordered breathing problem as identified by screening with questions from the Pediatric Sleep Questionnaire
  • suspected insomnia based on screening with questions from the Insomnia Severity Index
  • suspected Restless Leg Syndrome based on screening with the International RLS Study Group questionnaire
  • suspected delayed sleep phase syndrome as evidenced by consistent inability to fall asleep before 01h00 to 06h00, significant impairment in the ability to attend school due to extreme delay of their sleep schedule, and avoidance of other social or family functions in the daytime

Key Trial Info

Start Date :

January 26 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 28 2018

Estimated Enrollment :

65 Patients enrolled

Trial Details

Trial ID

NCT04089007

Start Date

January 26 2018

End Date

June 28 2018

Last Update

November 19 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Toronto

Toronto, Ontario, Canada, M5T 1P8